Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of SPH3127 tablets in diabetic kidney disease
CTR20221355Phase 2Completed
- Sponsor
- Shanghai Pharmaceuticals Holding Co Ltd
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitokiren in diabetic glomerulosclerosis, sponsored by Shanghai Pharmaceuticals Holding Co Ltd. Started Jun 2022; status: completed.
02
Drugs
sitokiren
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20221355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221355.